These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 31448268)

  • 21. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Highlights from the Faraday Discussion 296: quantum effects in small molecular systems, 10-12 September 2018, Edinburgh, United Kingdom.
    Ban L; Besemer M; Mouhib H
    Chem Commun (Camb); 2018 Dec; 54(97):13620-13625. PubMed ID: 30474085
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "That was not the discussion we wanted to have": Engagement of civil society organizations with synthetic biology.
    Fuchs D; Bauer A; Bogner A
    Public Underst Sci; 2023 Aug; 32(6):676-690. PubMed ID: 37092655
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scientific basis of the OCRA method for risk assessment of biomechanical overload of upper limb, as preferred method in ISO standards on biomechanical risk factors.
    Colombini D; Occhipinti E
    Scand J Work Environ Health; 2018 Jul; 44(4):436-438. PubMed ID: 29961081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
    J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthetic biology and intellectual property rights: six recommendations.
    Minssen T; Rutz B; van Zimmeren E
    Biotechnol J; 2015 Feb; 10(2):236-41. PubMed ID: 25676051
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthetic biology regulation and governance: Lessons from TAPIC for the United States, European Union, and Singapore.
    Trump BD
    Health Policy; 2017 Nov; 121(11):1139-1146. PubMed ID: 28807332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards a European strategy for medicines research (2014-2020): The EUFEPS position paper on Horizon 2020.
    Gaspar R; Aksu B; Cuine A; Danhof M; Takac MJ; Linden HH; Link A; Muchitsch EM; Wilson CG; Ohrngren P; Dencker L
    Eur J Pharm Sci; 2012 Dec; 47(5):979-87. PubMed ID: 23046836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Automation Opportunities in Pharmacovigilance: An Industry Survey.
    Ghosh R; Kempf D; Pufko A; Barrios Martinez LF; Davis CM; Sethi S
    Pharmaceut Med; 2020 Feb; 34(1):7-18. PubMed ID: 32036574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Investing in our nation's future military leaders' synthetic biology knowledge to understand and recognize threats and applications.
    Steel JJ; Bates KL; Barnhart MD
    Synth Biol (Oxf); 2019; 4(1):ysz024. PubMed ID: 33033745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Image of Synthetic Biology and Nanotechnology: A Survey among University Students.
    Ineichen C; Biller-Andorno N; Deplazes-Zemp A
    Front Genet; 2017; 8():122. PubMed ID: 28979291
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in Synthetic Biology Applications, Tools, Industry, and Oversight and Their Security Implications.
    Carter SR; Warner CM
    Health Secur; 2018; 16(5):320-333. PubMed ID: 30339097
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Construction in year 2030: developing an information technology vision.
    Erdogan B; Abbott C; Aouad G
    Philos Trans A Math Phys Eng Sci; 2010 Aug; 368(1924):3551-65. PubMed ID: 20603367
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Committee on Natural Toxins and Food Allergens. Marine and freshwater toxins.
    Hungerford JM
    J AOAC Int; 2005; 88(1):299-313. PubMed ID: 15759755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Review of quantitative and qualitative studies on U.S. public perceptions of synthetic biology.
    Pauwels E
    Syst Synth Biol; 2009 Dec; 3(1-4):37-46. PubMed ID: 19816798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Seizing the strategic opportunities of emerging technologies by building up innovation system: monoclonal antibody development in China.
    Zhang MY; Li J; Hu H; Wang YT
    Health Res Policy Syst; 2015 Nov; 13():64. PubMed ID: 26537659
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Conscious sedation guidance.
    Coulthard P
    Evid Based Dent; 2006; 7(4):90-1. PubMed ID: 17187034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Current and Future Challenges in Point-of-Care Technologies: A Paradigm-Shift in Affordable Global Healthcare With Personalized and Preventive Medicine.
    Dhawan AP; Heetderks WJ; Pavel M; Acharya S; Akay M; Mairal A; Wheeler B; Dacso CC; Sunder T; Lovell N; Gerber M; Shah M; Senthilvel SG; Wang MD; Bhargava B
    IEEE J Transl Eng Health Med; 2015; 3():2800110. PubMed ID: 27170902
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.